Cargando…
Allopurinol Use and the Risk of Type 2 Diabetes Mellitus: A Meta-Analysis of Cohort Studies
OBJECTIVE: To assess whether there is a relation between allopurinol use and the probability of type 2 diabetes mellitus (T2DM) in persons with gout and/or hyperuricemia. METHODS: According to the PRISMA 2020 guidelines, a meta-analysis was performed by searching literature published from 2000 to 20...
Autores principales: | Lai, Shih-Wei, Hwang, Bing-Fang, Kuo, Yu-Hung, Liu, Chiu-Shong, Liao, Kuan-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459475/ https://www.ncbi.nlm.nih.gov/pubmed/36091718 http://dx.doi.org/10.1177/15593258221123677 |
Ejemplares similares
-
A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2021) -
A meta-analysis of allopurinol therapy and the risk of prostate cancer
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
Allopurinol use and the risk of dementia: A meta-analysis of case–control studies
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
The incidence of herpes zoster in patients with diabetes mellitus: A meta-analysis of cohort studies
por: Lai, Shih-Wei, et al.
Publicado: (2021)